이 페이지는 자동 번역되었으며 번역의 정확성을 보장하지 않습니다. 참조하십시오 영문판 원본 텍스트의 경우.

The Effect Of Photobiomodulation On Dental Implant Survival

2026년 6월 3일 업데이트: Nida GEÇGİL, Nigde Omer Halisdemir University

The Effect of Photobiomodulation on Inflammation Levels and Stability Following Dental Implantation: A Randomised, Single-Blind, Controlled Study

Dental implants offer a high success rate as the most up-to-date treatment method for replacing lost teeth. However, whilst implants have emerged as the ideal treatment for tooth loss, the incidence of postoperative complications-including postoperative oedema, wound infection, and early dehiscence or perforation of the soft tissue flap-has also increased. The soft tissue surrounding the implant forms a strong barrier to prevent bacteria and metabolic by-products from entering deeper tissues and colonising the implant surface. Complications related to soft tissue can negatively affect implant success by leading to bacterial invasion in the early stages. Therefore, the rapid establishment of effective soft tissue sealing is crucial for establishing and maintaining the health of peri-implant tissues. Consequently, the search for a method capable of supporting the healing of soft tissues around the implant is a significant area of research in modern dental implantology. The primary stability of dental implants is defined by the biomechanical stability achieved during implant placement. The quantity and quality of the residual bone are key determinants of primary stability. The process continues with secondary stability, during which osseointegration is expected. As osseointegration requires complete structural and functional bonding between the living tissue and the implant surface, it is influenced by numerous factors. Low-level laser therapy or photobiomodulation (PBM) has been proposed as a method that may support osseointegration by reducing healing time in preclinical and clinical studies.

PBM involves the use of light across a broad wavelength range from red to infrared to produce analgesic, anti-inflammatory and biological stimulation effects. Different wavelengths are selected depending on the desired effect. The 660 nm wavelength (red light) increases adenozin tri phosphate (ATP) production, which provides energy for cellular repair and regeneration, and alters mitochondrial membrane potential. It also aids tissue healing by promoting collagen synthesis. The 808 nm wavelength (near-infrared light) penetrates deeper into tissues, reducing inflammatory responses by regulating reactive oxygen species and cytokine levels. There is no specific guideline regarding which wavelength of PBM should be applied for osseointegration and soft tissue healing. In this study, drawing on similar studies, two different wavelengths were examined to demonstrate the described effects. Resonance frequency analysis (RFA) is recognised as a commonly used and reliable method for measuring the stability of dental implants. RFA analysis is performed using specialised devices containing a 'smart pin' placed in the implant or abutment to quantify stability numerically. The implant stability quotient (ISQ) is presented using a numerical scale ranging from 0 to 100, and a higher ISQ value indicates better overall stability.

Following dental implant surgery, patients exhibit varying degrees of inflammatory signs. Among these signs, pain typically peaks 24 to 72 hours after surgery and then gradually subsides in a physiological manner. Pain is a significant parameter affecting the patient's quality of life and is a finding that must be considered when monitoring the process. For this reason, our study includes measurements of the Healing Index (HI), Modified Sulcus Bleeding Index (mSBI), and Gingival Index (GI), as well as Visual Analogue Scale (VAS) scores.

The aim of this clinical, prospective, comparative study is to evaluate the effect of 808 nm diode laser PBM on implant stability using RFA measurements, and the effect of 660 nm diode laser PBM on inflammation, pain, and postoperative healing.

연구 개요

상세 설명

No reference to a name or number is given in the 'brief summary'.

연구 유형

중재적

등록 (실제)

50

단계

  • 1단계

연락처 및 위치

이 섹션에서는 연구를 수행하는 사람들의 연락처 정보와 이 연구가 수행되는 장소에 대한 정보를 제공합니다.

연구 장소

    • Niğde Province
      • Niğde, Niğde Province, 터키 (Türkiye)
        • Nigde Omer Halisdemir University

참여기준

연구원은 적격성 기준이라는 특정 설명에 맞는 사람을 찾습니다. 이러한 기준의 몇 가지 예는 개인의 일반적인 건강 상태 또는 이전 치료입니다.

자격 기준

공부할 수 있는 나이

  • 성인

건강한 자원 봉사자를 받아들입니다

예

설명

Inclusion Criteria:

  • • Male and female patients aged between 18 and 55

    • Patients who are mentally and physically healthy
    • Patients with missing teeth of the same number on both sides of the maxilla or mandible, and who are suitable candidates for dental implants
    • Patients who volunteer for the study, sign the consent form and attend follow-up appointments
    • Patients who smoke five or fewer cigarettes per day

Exclusion Criteria:

  • • Patients who smoke

    • Patients taking medication that affects bone quality or who have a systemic disease
    • Patients with psychiatric disorders
    • Pregnant or breastfeeding women
    • Patients with parafunctional habits such as bruxism
    • Patients with suspected cysts or tumours in the implant site, or those requiring grafting
    • Unilateral implant cases

공부 계획

이 섹션에서는 연구 설계 방법과 연구가 측정하는 내용을 포함하여 연구 계획에 대한 세부 정보를 제공합니다.

연구는 어떻게 설계됩니까?

디자인 세부사항

  • 주 목적: 건강 서비스 연구
  • 할당: 무작위
  • 중재 모델: 병렬 할당
  • 마스킹: 하나의

무기와 개입

참가자 그룹 / 팔
개입 / 치료
간섭 없음: control group
In 50 participants, non-irradiating light of the same colour as the implant will be applied to one side of the mouth using photobiomodulation
실험적: intervention group
In 50 participants, photobiomodulation will be applied to the other side of the mouth
Photobiomodulation will be applied to the implant located on one side of the mouth in 50 participants

연구는 무엇을 측정합니까?

주요 결과 측정

결과 측정
측정값 설명
기간
One of the primary outcomes of this study is to investigate the effects of low-level laser therapy on the periodontal healing of dental implants using clinical scales.
기간: 2 weeks
The effect of low-level laser therapy on periodontal healing following dental implant placement will be assessed 7 days after the procedure using the Healing Index (HI). This index indicates a final HI score ranging from 0 for poor healing to 5 for excellent healing. In addition, the modified sulcus bleeding index (mSBI) will be used on the same day (7 days after the procedure) to assess bleeding. Scores from 4 surfaces will be recorded to calculate the average score. The scoring criteria will be as follows: 0 = no bleeding at the gingival margin; 1 = isolated punctate bleeding; 2 = linear swelling in the gingival sulcus; 3 = severe or spontaneous bleeding. As both scores indicate periodontal healing, these scores have been combined into a single outcome measure.
2 weeks
The effect of low-level laser therapy on the level of inflammation following dental implant placement
기간: 2 weeks
The effect of low-level laser therapy on the level of inflammation following dental implant surgery will be assessed 7 days after the procedure using the Visual Analogue Scale (VAS). On this scale, patients will be asked to rate their pain numerically on a scale of 1 (no pain) to 10 (severe pain).
2 weeks
An investigation into the effect of low-level laser therapy on the stability of dental implants using resonance frequency analysis.
기간: 12 weeks
The effect of low-level laser therapy on the stability of dental implants will be measured using resonance frequency analysis. This measurement will be taken immediately after surgery and at the 3-month follow-up. The measuring device measures metal vibration via a conductive interface and provides a numerical value between 0 and 90. Numerical values of 70 or above will indicate sufficient stability.
12 weeks

공동 작업자 및 조사자

여기에서 이 연구와 관련된 사람과 조직을 찾을 수 있습니다.

수사관

  • 연구 책임자: NİDA GEÇKİL, assoc.prof., Nigde Omer Halisdemir University

연구 기록 날짜

이 날짜는 ClinicalTrials.gov에 대한 연구 기록 및 요약 결과 제출의 진행 상황을 추적합니다. 연구 기록 및 보고된 결과는 공개 웹사이트에 게시되기 전에 특정 품질 관리 기준을 충족하는지 확인하기 위해 국립 의학 도서관(NLM)에서 검토합니다.

연구 주요 날짜

연구 시작 (실제)

2025년 10월 15일

기본 완료 (실제)

2026년 4월 15일

연구 완료 (실제)

2026년 4월 15일

연구 등록 날짜

최초 제출

2026년 4월 16일

QC 기준을 충족하는 최초 제출

2026년 6월 3일

처음 게시됨 (실제)

2026년 6월 9일

연구 기록 업데이트

마지막 업데이트 게시됨 (실제)

2026년 6월 9일

QC 기준을 충족하는 마지막 업데이트 제출

2026년 6월 3일

마지막으로 확인됨

2026년 6월 1일

추가 정보

이 연구와 관련된 용어

기타 연구 ID 번호

  • NigdeOHUDentistry

개별 참가자 데이터(IPD) 계획

개별 참가자 데이터(IPD)를 공유할 계획입니까?

아니요

약물 및 장치 정보, 연구 문서

미국 FDA 규제 의약품 연구

아니

미국 FDA 규제 기기 제품 연구

아니

미국에서 제조되어 미국에서 수출되는 제품

아니

이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .

구독하다